| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on April 10, 2002
Accepted on May 16, 2002
From The Scripps Research Institute, Department of Immunology, La Jolla, Calif.
* To whom correspondence should be addressed. E-mail: lcurtiss{at}scripps.edu.
ObjectiveNatural killer (NK) cells have been identified in human vascular pathologies. In this study, we identified NK cells in aortic root atherosclerotic lesions of low density lipoprotein (LDL) receptor--deficient (LDLr-/-) mice. To characterize the role of NK cell--mediated cytolysis in atherosclerosis, we generated C57Bl/6 double-mutant mice by crossing LDLr-/- mice with NK cell--defective Lystbeige mice (creating beige,LDLr-/- mice) and with perforin-deficient mice (creating Pfp-/-,LDLr-/- mice).
Methods and ResultsMale mice (8 to 10 weeks old) were fed a high-fat diet to induce atherosclerosis. Compared with LDLr-/- mice, beige,LDLr-/- mice had impaired NK cell cytolytic activity and significantly increased atherosclerosis (P<0.05). Pfp-/-,LDLr-/- mice had impaired NK cell cytolytic activity, yet they had lesions that were similar to those of control mice. This suggested that NK cell cytolysis did not play a significant role in atherosclerosis and that the exacerbated atherosclerosis of the beige,LDLr-/- mouse was independent of impaired NK cell cytolytic activity. Therefore, we investigated the role of T and B lymphocytes in atherosclerosis of beige mice by crossing them with recombinase activator gene 1--deficient LDLr-/- mice (Rag1-/-,LDLr-/- mice), thus creating beige,Rag1-/-,LDLr-/- mice. As in the double-mutant study, beige,Rag1-/-,LDLr-/- mice had significantly increased lesions compared with Rag1-/-,LDLr-/- control mice.
ConclusionsTherefore, the Lystbeige mutation in LDLr-/- mice has proatherogenic properties that are independent of NK cell--mediated cytolysis and lymphocyte-mediated acquired immunity.
This article has been cited by other articles:
![]() |
R. J. Petrovan, Y. Yuan, and L. K. Curtiss Expression of the Lystbeige mutation is atheroprotective in chow-fed apolipoprotein E-deficient mice J. Lipid Res., February 1, 2008; 49(2): 429 - 437. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. VanderLaan and C. A. Reardon Thematic review series: The Immune System and Atherogenesis. The unusual suspects:an overview of the minor leukocyte populations in atherosclerosis J. Lipid Res., May 1, 2005; 46(5): 829 - 838. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Getz Bridging the innate and adaptive immune systems J. Lipid Res., April 1, 2005; 46(4): 619 - 622. [Full Text] [PDF] |
||||
![]() |
N. K. Schiller, A. S. Black, G. P. Bradshaw, D. J. Bonnet, and L. K. Curtiss Participation of macrophages in atherosclerotic lesion morphology in LDLr-/- mice J. Lipid Res., August 1, 2004; 45(8): 1398 - 1409. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Linton, A. S. Major, and S. Fazio Proatherogenic Role for NK Cells Revealed Arterioscler Thromb Vasc Biol, June 1, 2004; 24(6): 992 - 994. [Full Text] [PDF] |
||||
![]() |
S. C. Whitman, D. L. Rateri, S. J. Szilvassy, W. Yokoyama, and A. Daugherty Depletion of Natural Killer Cell Function Decreases Atherosclerosis in Low-Density Lipoprotein Receptor Null Mice Arterioscler Thromb Vasc Biol, June 1, 2004; 24(6): 1049 - 1054. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Getz Do Natural Killer Cells Participate in a Killer Vascular Disease? Arterioscler Thromb Vasc Biol, August 1, 2002; 22(8): 1251 - 1253. [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |